Full-Time

Senior Manager

Market Access, Cardiology

Confirmed live in the last 24 hours

Baxter International

Baxter International

10,001+ employees

Provides essential medical products and services

Compensation Overview

$128k - $176kAnnually

+ Bonus

Senior, Expert

No H1B Sponsorship

Remote in USA

Remote work is allowed, but candidates are preferred from specific locations including St. Paul/Minneapolis, Deerfield, Bellevue, Houston, and New Providence.

Category
Insurance
Finance & Banking
Requirements
  • Bachelor’s degree is required with focus on healthcare, including nursing, health economics, public health or business.
  • At least 10 years required Healthcare Reimbursement/Medical Device related experience with demonstrable evidence of successfully partnering with customers and achieving shared goals and outcomes; cardiac space is ideal; medical device or pharmaceutical.
  • Possess extensive knowledge of Medicaid, Medicare, reimbursements and programs, Federal Marketplace (VA/DoD), Regional Health Plans and National Health Plans.
  • Proven track record in reimbursement development for new technologies and coverage expansion of clinical indications for existing technologies.
  • Expertise in government and commercial plans, payer systems and knowledge of industry trends in pricing and reimbursement.
  • Understanding of healthcare regulatory requirements, payment methodologies, CPT and HCPCS coding, compliance, third party billing, appeals and external payer audits.
  • Ability to read sophisticated payer/government regulations and policies.
  • Verbal, written and presentation skills for various audiences, including regulatory and clinical content.
Responsibilities
  • Develop and implement Market Access strategy for cardiology products, including reimbursement development and payer policy development/revisions, with teamwork from health economics and outcomes research (HEOR), marketing, sales, research and development, medical and government affairs.
  • Assess and communicate the coding, coverage and payment landscape for current and new devices.
  • Develop and execute specific strategies to enable efficient reimbursement and coverage for patients.
  • Develop and effectively communicate clinical and economic value propositions to payer decision makers.
  • Negotiate coverage, pricing and policy language with government and commercial payers for cardiac monitoring services.
  • Strategic thought leader regarding the Market Access landscape, as it relates to changes in payer coverage and payment policies, strategy and reimbursement development for new products, coverage expansion opportunities for existing products.
  • Lead the effort of building and growing long term executive level account relationships with targeted national and regional payers.
  • Proactively identifying market trends, key market access customers and opinion leaders on a continual basis.
  • Work with the Director of Market Access, FLC Marketing, Government Affairs, Medical Affairs, Health Economics, Legal / Compliance as well as external KOLs, patient advocacy groups and select consultants to build access and favorable reimbursement for the Cardiology portfolio products.
  • Ability to travel 25%, depending on demands of current initiatives and key meetings with both internal and external customers/stakeholders. Overnight travel may be required.
Desired Qualifications
  • Experience in developing/growing reimbursement (coding, coverage, and payment) for new technologies, and across commercial and government payers, preferred.
  • Experience in rapidly growing reimbursement for independent diagnostic testing facilities (IDTF), preferred.

Baxter International provides a wide range of medical products and services essential for healthcare. The company operates in several areas, including critical care, hospital care, nutritional care, renal care, and surgical care. Its products are used in various settings, from emergency rooms to home healthcare, helping to meet the needs of patients and healthcare professionals globally. Baxter develops, manufactures, and distributes medical devices, pharmaceuticals, and biotechnology products, generating revenue through sales to healthcare providers and institutions. A key aspect that sets Baxter apart from competitors is its recent acquisition of Hillrom, which enhances its ability to offer comprehensive healthcare solutions. The company's goal is to improve care outcomes and increase access to healthcare through continuous innovation and a focus on patient needs.

Company Size

10,001+

Company Stage

IPO

Headquarters

Deerfield, Illinois

Founded

1931

Simplify Jobs

Simplify's Take

What believers are saying

  • Baxter's investment in Medically Home aligns with the growing home healthcare market.
  • Rising demand for personalized medicine offers Baxter opportunities for targeted therapies.
  • Expansion in telehealth supports Baxter's integrated healthcare solutions strategy.

What critics are saying

  • Needle-free injection technology could disrupt Baxter's traditional injection-based therapies.
  • Shift to home healthcare may require Baxter to adapt its product offerings.
  • Growing digital health importance necessitates further investment from Baxter to stay competitive.

What makes Baxter International unique

  • Baxter's acquisition of Hillrom enhances its comprehensive healthcare solutions portfolio.
  • Strong focus on patient-centric innovation sets Baxter apart in the healthcare industry.
  • Baxter's partnerships, like with Ayogo, leverage digital health for improved patient outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Parental Leave

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Commuter Benefits

Mental Health Support

Company News

TechCrunch
Mar 31st, 2022
Novaxs Biotech Raises $1.5M To Make Injection Therapy Needle-Free

A startup spawned from a lab at the University of California, Berkeley has won investor support to work on its patented needle-free injector, which it hopes can make therapies that traditionally require daily self-administered medicines less painful. NovaXS Biotech, founded by 21-year-old Berkeley researcher Alina Su in 2020, recently closed a $1.5 million seed round []

PR Newswire
Jan 10th, 2022
Medically Home Announces a $110 Million Strategic Investment Led by Baxter International Inc., Global Medical Response and Cardinal Health to Advance Leadership in Hospital-Level Patient Care at Home

/PRNewswire/ -- Medically Home today announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global...

s29755.pcdn.co
Sep 12th, 2020
Canfor, 4 others named FourKites Golden Kite Award winners

Five companies have been named FourKites Golden Kite Award winners for their successful integration of, and results from, using FourKites technology to improve customer service and operations.

FreightWaves
Sep 12th, 2020
Canfor, 4 others named FourKites Golden Kite Award winners

Five companies have been named FourKites Golden Kite Award winners for their successful integration of, and results from, using FourKites technology to improve customer service and operations.

CanHealth
Aug 5th, 2020
Baxter and Ayogo partner on home dialysis

DEERFIELD, Ill. and VANCOUVER, BC – Baxter International Inc., a global innovator in renal care, and Ayogo Health Inc., a behavioral science-based digital health company, announced the expansion of their partnership to support the needs of patients with kidney disease through digital health solutions. Ayogo is